Clinical Trials

Sponsor: COG

Sponsor Study ID: AR11055

Study Title: Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias

CTO #: 103598

NCT Number: NCT04726241

Phase: N/A

Protocol Type: Screening

Age Group: Both

Disease Sites: Myeloid and Monocytic Leukemia

Study Objectives: To utilize clinical and biological characteristics of acute leukemias to screen for patient eligibility for available Phase I/II PedAL sub-trials. To maintain a longitudinal and comprehensive registry from relapse in children and young adults with recurrent and refractory leukemia.



Study Documents    
(MUSC NetID required for document access)